Drugs / [F-18]-fluoro-L-thymidine
[F-18]-fluoro-L-thymidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01143779 | Jun 2010 → Dec 2021 | — | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [F-18]-fluoro-L-thymidine | “an imaging solution, \[F-18\]-fluoro-L-thymidine (FLT), when used with a positron emission tomography (PET) scan” NCT01143779 ↗ |
| Modality | Diagnostic / imaging agent | “an imaging solution, \[F-18\]-fluoro-L-thymidine (FLT), when used with a positron emission tomography (PET) scan” NCT01143779 ↗ |
| Route | Intravenous | “You will receive the FLT solution by vein.” NCT01143779 ↗ |